FDA Approves Expanded Indication for Dovato to Include Adolescent Patients with HIV

1 min read

Dovato is the first oral, two-drug, single-tablet regimen approved for patients 12 years of age and older who are living with HIV-1.

You May Also Like

More From Author

+ There are no comments

Add yours